THE ALPHA-1C CALCIUM CHANNEL IN MUSCLE
肌肉中的 ALPHA-1C 钙通道
基本信息
- 批准号:6390575
- 负责人:
- 金额:$ 32.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-27 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting RNase protection assay calcium channel dexamethasone electrophysiology electrostimulus gel mobility shift assay gene expression immunocytochemistry laboratory rat microarray technology muscle contraction muscle function myocardium nucleic acid sequence polymerase chain reaction statistics /biometry staurosporine striated muscles tissue /cell culture transcription factor voltage /patch clamp western blottings
项目摘要
DESCRIPTION (Adapted from the applicant's abstract): L-type voltage-gated
calcium channels also known as dihydropyridine receptors (DHPRs) are critical
for excitation-contraction coupling in both skeletal and cardiac muscle. Each
of these muscle types expresses its own isoform of the DHPR. The role of the
alpha1C cardiac DHPR in cardiac muscle is unquestionable to both provide the
influx of Ca2+ needed to trigger Ca2+ release from intracellular stores as well
as to provide a means to refill those stores when they become depleted. In
vascular smooth muscle these same channels are the site of action of nearly all
Ca2+ channel blockers used therapeutically in the treatment of hypertension and
heart disease. Recently certain adult skeletal muscles have been shown to
exhibit not only the alpha1S skeletal isoform of the DHPR, but also the alpha1C
cardiac isoform, although at lower levels of expression. This grant tests
several hypotheses for the role of the cardiac DHPR in adult skeletal muscle.
The hypotheses to be tested include refilling of partially depleted
intracellular Ca2+ stores, forestalling fatigue, and serving to turn off other
genes. Methods will include tension, (Ca2+)i and electrophysiology measurements
and measurements of gene expression. The results may suggest additional roles
for the alpha1C cardiac DHPRs in the heart as well as in many smooth muscles.
This grant also seeks to determine how the steroid hormone dexamethasone, the
protein kinase C inhibitor staurosporine, and electrical stimulation regulate
the expression of the cardiac DHPR in muscle, and to determine the response
elements for the transcription factors involved and for tissue-specific
expression within the gene promoter. Additional methods will include
traditional assays used for promoter work. These results will enhance
understanding of the transcriptional regulation of this extremely important
receptor for therapeutic agents in the treatment of hypertension and heart
disease.
描述(改编自申请人的摘要):L 型电压门控
钙通道也称为二氢吡啶受体 (DHPR) 至关重要
用于骨骼肌和心肌的兴奋-收缩耦合。每个
这些肌肉类型表达其自己的 DHPR 同工型。的作用
心肌中的 α1C 心脏 DHPR 毫无疑问可以提供
Ca2+ 的流入也需要触发细胞内储存的 Ca2+ 释放
以便在这些商店耗尽时提供补充的方法。在
血管平滑肌 这些相同的通道是几乎所有血管的作用部位
Ca2+通道阻滞剂用于治疗高血压和
心脏病。最近,某些成人骨骼肌已被证明可以
不仅表现出 DHPR 的 alpha1S 骨骼亚型,还表现出 alpha1C
心脏亚型,尽管表达水平较低。本次资助测试
关于心脏 DHPR 在成人骨骼肌中的作用的几种假设。
要测试的假设包括补充部分耗尽的
细胞内 Ca2+ 储存,防止疲劳,并有助于关闭其他功能
基因。方法包括张力、(Ca2+)i 和电生理学测量
和基因表达的测量。结果可能会建议额外的角色
对于心脏以及许多平滑肌中的 α1C 心脏 DHPR。
这笔赠款还旨在确定类固醇激素地塞米松如何
蛋白激酶 C 抑制剂星形孢菌素和电刺激调节
肌肉中心脏 DHPR 的表达,并确定反应
所涉及的转录因子和组织特异性的元件
在基因启动子内表达。其他方法将包括
用于启动子工作的传统测定。这些结果将增强
了解这一极其重要的转录调控
治疗高血压和心脏病的药物受体
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP T. PALADE其他文献
PHILIP T. PALADE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP T. PALADE', 18)}}的其他基金
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
8389872 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
8015274 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
8197452 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
7785275 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
6731754 - 财政年份:2003
- 资助金额:
$ 32.74万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
6984144 - 财政年份:2003
- 资助金额:
$ 32.74万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
7215036 - 财政年份:2003
- 资助金额:
$ 32.74万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
6837154 - 财政年份:2003
- 资助金额:
$ 32.74万 - 项目类别: